Mineralys Therapeutics, INC. (MLYS) SEC Filings — 2025

Filings

• Mineralys Narrows Losses, Boosts Cash with $459M in Offerings — 10-Q · Nov 10, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Sep 3, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Sep 2, 2025
• Mineralys' Losses Mount Amid R&D Spend, Cash Position Strong — 10-Q · Aug 12, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Jun 17, 2025
• Mineralys Therapeutics Files 8-K — 8-K · May 22, 2025
• Mineralys Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
• Mineralys Therapeutics 2025 Annual Meeting Proxy Statement — DEF 14A · Apr 9, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Mar 31, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Mar 12, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Mar 10, 2025
• Mineralys Therapeutics, INC. 10-K Filing — 10-K · Feb 12, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Feb 4, 2025
• Mineralys Therapeutics Files 8-K — 8-K · Jan 8, 2025